JUNO THERAPEUTICS INC's ticker is JUNO and the CUSIP is 48205A109. A total of 214 filers reported holding JUNO THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 0.99 and the average weighting 0.9%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $319,692,000 | +6.1% | 6,993,901 | +4.1% | 0.01% | 0.0% |
| Q3 2017 | $301,269,000 | +60.4% | 6,715,753 | +6.8% | 0.01% | +55.6% |
| Q2 2017 | $187,879,000 | +37.6% | 6,285,676 | +2.1% | 0.01% | +28.6% |
| Q1 2017 | $136,553,000 | +23.8% | 6,153,812 | +5.2% | 0.01% | +16.7% |
| Q4 2016 | $110,271,000 | -34.8% | 5,849,900 | +3.8% | 0.01% | -40.0% |
| Q3 2016 | $169,075,000 | -19.6% | 5,633,937 | +3.0% | 0.01% | -23.1% |
| Q2 2016 | $210,331,000 | +15.9% | 5,471,650 | +14.8% | 0.01% | +8.3% |
| Q1 2016 | $181,481,000 | -10.6% | 4,764,510 | +3.2% | 0.01% | -14.3% |
| Q4 2015 | $202,937,000 | -43.0% | 4,615,355 | -47.3% | 0.01% | +7.7% |
| Q3 2015 | $356,220,000 | +377.9% | 8,754,490 | +526.3% | 0.01% | +160.0% |
| Q2 2015 | $74,546,000 | -9.2% | 1,397,829 | +3.3% | 0.01% | -16.7% |
| Q1 2015 | $82,081,000 | +2145.7% | 1,353,132 | +1833.0% | 0.01% | – |
| Q4 2014 | $3,655,000 | – | 70,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|